Glauco helps to improve optic nerve function and reduces ganglion cells damage in pets with glaucoma.
Glauco’s composition includes active ingredients such as Ginkgo biloba and Vaccinium myrtillus which have neuroprotective properties essential to improve optic nerve’s activity and delay retinal ganglion cells damage in glaucoma, and also, help reducing the degradation of the trabecular meshwork of the eye.
COMPOSITION PER TABLET (750mg):
INGREDIENTS: Ginkgo biloba L.: Ginkgo extract (48mg), Vaccinium
myrtillus (24mg), Dicalcium phosphate (400mg), Magnesium stearate (10mg).
ADDITIVES:
Oral administration, once daily, with one of the main meals.
Each package contains 30 tablets of 750mg.
Store in a cool and dry place, protected from light.
(3) Glauco - Vademecum ENG v02
